FdaApplication
ANDA 205024
Identifiers
- fda_app_no: ANDA205024
Properties
| Property | Value |
|---|---|
| applicant_name | QUAGEN PHARMACEUTICALS LLC |
| application_type | ANDA |
| approval_date | 2024-02-16 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| RITONAVIR | RITONAVIR | 100MG | CAPSULE;ORAL |
1 product